Gilead Sciences Inc (GILD)

Return on assets (ROA)

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Net income (ttm) US$ in thousands 5,664,000 5,875,000 5,484,000 5,583,000 4,592,000 3,334,000 4,137,000 4,515,000 6,225,000 7,394,000 5,162,000 301,000 123,000 1,268,000 -257,000 4,962,000 5,386,000 2,693,000 5,955,000 5,892,000
Total assets US$ in thousands 62,125,000 62,373,000 62,337,000 61,876,000 63,171,000 62,557,000 62,870,000 63,080,000 67,952,000 67,098,000 67,984,000 67,492,000 68,407,000 60,878,000 55,934,000 59,741,000 61,627,000 59,146,000 63,210,000 62,837,000
ROA 9.12% 9.42% 8.80% 9.02% 7.27% 5.33% 6.58% 7.16% 9.16% 11.02% 7.59% 0.45% 0.18% 2.08% -0.46% 8.31% 8.74% 4.55% 9.42% 9.38%

December 31, 2023 calculation

ROA = Net income (ttm) ÷ Total assets
= $5,664,000K ÷ $62,125,000K
= 9.12%

The return on assets (ROA) for Gilead Sciences, Inc. has been relatively stable over the past eight quarters, ranging between 5.33% and 9.42%.

The company's ROA peaked in Q3 2023 at 9.42%, indicating that for every dollar of assets, Gilead generated a profit of 9.42 cents. This was a positive sign as it showed improved efficiency in the utilization of the company's assets to generate earnings.

Overall, Gilead's ROA performance demonstrates consistent profitability and efficiency in utilizing its assets to generate earnings over the analyzed period. The upward trend in the ROA figures in recent quarters is a positive indicator of the company's operational performance and financial health.


Peer comparison

Dec 31, 2023


See also:

Gilead Sciences Inc Return on Assets (ROA) (Quarterly Data)